Bliss GVS Pharma Limited (NSE:BLISSGVS)
India · Delayed Price · Currency is INR 447.20
-20.40 (-4.36%)
Jul 22, 2026, 3:30 PM IST
Bliss GVS Pharma Cash Flow Statement
Financials in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Net Income | 1,291 | 842.99 | 754.54 | 708.59 | 150.4 |
Depreciation & Amortization | 334.14 | 293.21 | 262.57 | 185.13 | 171.33 |
Other Amortization | 0.69 | 0.97 | 1.23 | 1.61 | 1.98 |
Loss (Gain) From Sale of Assets | 21.09 | 4.92 | -2.86 | -3.65 | -1.38 |
Asset Writedown & Restructuring Costs | 5.42 | - | - | - | - |
Loss (Gain) From Sale of Investments | 339.12 | 25.75 | - | - | - |
Stock-Based Compensation | 86.24 | 41.4 | 38.16 | 39.04 | 57.08 |
Provision & Write-off of Bad Debts | 242.72 | 214.88 | 252.74 | 228.07 | 227.8 |
Other Operating Activities | 110.91 | 149.58 | 187.5 | 35.54 | 13.87 |
Change in Accounts Receivable | -883.65 | -415.89 | -445.19 | -149.98 | 512.91 |
Change in Inventory | -455 | -304.54 | -224.22 | 150.03 | -290.97 |
Change in Accounts Payable | 326.16 | 108.38 | -251 | -63.16 | 183.44 |
Change in Other Net Operating Assets | -31.96 | 97.49 | 454.7 | -788.08 | 328.34 |
Operating Cash Flow | 1,387 | 1,059 | 1,028 | 343.14 | 1,355 |
Operating Cash Flow Growth | 30.97% | 3.01% | 199.64% | -74.67% | 111.79% |
Capital Expenditures | -568.31 | -762.86 | -283.29 | -937.99 | -740.03 |
Sale of Property, Plant & Equipment | 25.35 | 34.12 | 6.03 | 6.91 | 10.68 |
Cash Acquisitions | -2.23 | - | - | - | - |
Divestitures | 85.14 | - | - | - | - |
Investment in Securities | -93.19 | -191.7 | 539.54 | -54.58 | -22.31 |
Other Investing Activities | 170.45 | 164.56 | -1,094 | 908.15 | -178.09 |
Investing Cash Flow | -382.8 | -755.87 | -831.9 | -77.51 | -929.75 |
Long-Term Debt Issued | 42.53 | 552.73 | 154.88 | 400.22 | 107.56 |
Long-Term Debt Repaid | -693.9 | -762.34 | -272.36 | -552.68 | -284.81 |
Net Debt Issued (Repaid) | -651.37 | -209.61 | -117.48 | -152.46 | -177.26 |
Issuance of Common Stock | 18 | 28.86 | 23.5 | 20.42 | 22.84 |
Common Dividends Paid | -106.37 | -53.95 | -53.95 | -54.37 | -53.27 |
Other Financing Activities | -152.38 | -67.29 | -61 | -62.97 | -29.62 |
Financing Cash Flow | -892.11 | -301.98 | -208.93 | -249.39 | -237.3 |
Foreign Exchange Rate Adjustments | 0.97 | 0.99 | -1.5 | 13.96 | -99.23 |
Net Cash Flow | 113.25 | 2.26 | -14.16 | 30.2 | 88.53 |
Free Cash Flow | 818.87 | 296.27 | 744.87 | -594.86 | 614.78 |
Free Cash Flow Growth | 176.39% | -60.23% | - | - | 12.09% |
Free Cash Flow Margin | 8.83% | 3.66% | 9.67% | -7.92% | 8.22% |
Free Cash Flow Per Share | 7.61 | 2.79 | 7.02 | -5.64 | 5.84 |
Cash Interest Paid | 149.34 | 68.21 | 61 | 62.97 | 29.62 |
Cash Income Tax Paid | 416.52 | 366.36 | 348.51 | 445.55 | 339.43 |
Levered Free Cash Flow | 949.59 | 155.03 | 19.06 | -184.61 | 1,059 |
Unlevered Free Cash Flow | 1,025 | 205.78 | 56.88 | -122.96 | 1,082 |
Change in Working Capital | -1,044 | -514.56 | -465.71 | -851.19 | 733.73 |